RSR13 Approval Status
FDA Approved: No
Brand name: RSR13
Generic name: efaproxiral
Company: Allos Therapeutics, Inc.
Treatment for: Brain Metastases in patients with Breast Cancer
Development Status and FDA Approval Process for RSR13
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.